Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

pBFS Guided rTMS Treating Mild Alzheimer's Disease(AD)

NCT: NCT05872243 · COMPLETED

NCT IDNCT05872243
StatusCOMPLETED
Start Date2023-09-05
Completion2025-03-05
SponsorChangping Laboratory (OTHER)
First posted
Last updated

Brief Summary

This study aims to investigate the effectiveness and safety of rTMS treatment under the guidance of personalized Brain Functional Sectors (pBFS) for the cognitive ability of patients with mild Alzheimer's disease.

Frequently Asked Questions

What is pBFS Guided rTMS Treating Mild Alzheimer's Disease(AD)?

pBFS Guided rTMS Treating Mild Alzheimer's Disease(AD) is a clinical trial registered under NCT05872243. Current status: COMPLETED.

What is the status of NCT05872243?

The current status of NCT05872243 (pBFS Guided rTMS Treating Mild Alzheimer's Disease(AD)) is: COMPLETED.

When did pBFS Guided rTMS Treating Mild Alzheimer's Disease(AD) start?

pBFS Guided rTMS Treating Mild Alzheimer's Disease(AD) started on 2023-09-05.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.